Liquidia Corporation (LQDA)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$46.08
+4.18%
Mkt Cap $3.97B
Analyst Ratings
Buy
13
Hold
5
Sell
0
Price Target (30 analysts)
$98.11
Range $36.00 – $130.00
Implied Upside
+112.9%
Consensus $98.11 vs current $46.08